Vaccine, 0264-410X


View graph of relations

Related Publications
  1. A report on the status of vaccination in Europe

    Sheikh, S., Biundo, E., Courcier, S., Damm, O., Launay, O., Maes, E., Marcos, C., Matthews, S., Meijer, C., Poscia, A., Postma, M., Saka, O., Szucs, T. & Begg, N. 9-Aug-2018 In : Vaccine. 36, 33, p. 4979-4992 14 p.

    Research output: Contribution to journalReview article

  2. The cost-effectiveness of trivalent and quadrivalent influenza vaccination in communities in South Africa, Vietnam and Australia

    de Boer, P. T., Kelso, J. K., Halder, N., Nguyen, T-P-L., Moyes, J., Cohen, C., Barr, I. G., Postma, M. J. & Milne, G. J. 8-Feb-2018 In : Vaccine. 36, 7, p. 997-1007 11 p.

    Research output: Contribution to journalArticle

  3. Tetanus Toxoid carrier protein induced T-helper cell responses upon vaccination of middle-aged adults

    van der Heiden, M., Duizendstra, A., Berbers, G. A. M., Boots, A. M. H. & Buisman, A-M. 9-Oct-2017 In : Vaccine. 35, 42, p. 5581-5588 8 p.

    Research output: Contribution to journalArticle

  4. Influenza vaccination in healthcare workers: comparison of side effects and preferred route of administration of intradermal versus intramuscular administration

    Meijer, W. J., Wensing, A. M. J., Bos, A. A., Kuiphuis, J. C. F., Hagelen, E. M. M., Wilschut, J. C., de Vries, M. J. T. & Riezebos-Brilman, A. 13-Mar-2017 In : Vaccine. 35, 11, p. 1517-1523 7 p.

    Research output: Contribution to journalArticle

  5. Influenza vaccine effectiveness estimates in the Dutch population from 2003 to 2014: The test-negative design case-control study with different control groups

    van Doorn, E., Darvishian, M., Dijkstra, F., Donker, G. A., Overduin, P., Meijer, A. & Hak, E. 15-May-2017 In : Vaccine. 35, 21, p. 2831-2839 9 p.

    Research output: Contribution to journalArticle

View all (127) »

ID: 769190